Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03558087
Title Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Matthew Galsky
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Univerity of Southern California Los Angeles California 90033 United States Details
Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center New York New York 10029 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Penn Medicine Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
Huntsman Cancer Institute University of Utah Salt Lake City Utah 84112 United States Details
University of Wisconsin Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from for the field